Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
AngioDynamics, Inc. (often referred to simply as AngioDynamics) is a leading global medical technology company headquartered in the US. Founded in 1988, it operates within the dynamic medical, precision and optical instruments industry, focusing on innovative solutions for minimally invasive procedures.
The company specialises in designing, manufacturing, and selling medical devices used by interventional radiologists, nephrologists, and oncologists. Their core product portfolio, known for its technological advancements, includes devices for oncology, vascular access, and peripheral vascular disease, delivering improved patient outcomes.
AngioDynamics holds a significant position in the medical device market due to its commitment to pioneering solutions like the AngioVac System and NanoKnife Technology. These proprietary technologies underscore their dedication to advancing patient care across key therapeutic areas.
-14 vs industry average
AngioDynamics, Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
No reported emissions data is available for AngioDynamics, Inc. yet.
AngioDynamics, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their total emissions, including Scope 1, Scope 2, and Scope 3 emissions, are not provided.
Furthermore, AngioDynamics has not outlined any specific reduction targets or commitments related to climate initiatives. The absence of documented climate pledges or targets indicates that the company may still be in the early stages of developing a comprehensive sustainability strategy.
In the context of the medical device industry, companies are increasingly recognising the importance of addressing carbon emissions and implementing climate action plans. However, without specific data or commitments from AngioDynamics, it is unclear how they align with industry standards or expectations regarding climate responsibility.
No climate goals have been disclosed for AngioDynamics, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more